Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
PURPOSE: Nonadherence to hormone therapy in breast cancer survivors is common and associated with increased risk of mortality. Consistent predictors of nonadherence and nonpersistence are yet to be identified, and little research has examined psychosocial factors that may be amenable to change through intervention. This review aimed to identify predictors of nonadherence and nonpersistence to hormone therapy in breast cancer survivors in order to inform development of an intervention to increase adherence rates. METHODS: Studies published up to April 2016 were identified through MEDLINE, Embase, Web of Science, PsycINFO, CINAHL and gray literature. Studies published in English measuring associations between adherence or persistence and any predictor variables were included. Eligible studies were assessed for methodological quality, data were extracted and a narrative synthesis was conducted. RESULTS: Sixty-one eligible articles were identified. Most studies focused on clinical and demographic factors with inconsistent results. Some evidence suggested that receiving specialist care and social support were related to increased persistence, younger age and increased number of hospitalizations were associated with nonadherence, and good patient-physician relationship and self-efficacy for taking medication were associated with better adherence. A small amount of evidence suggested that medication beliefs were associated with adherence, but more high-quality research is needed to confirm this. CONCLUSION: Some psychosocial variables were associated with better adherence and persistence, but the results are currently tentative. Future high-quality research should be carried out to identify psychosocial determinants of nonadherence or nonpersistence that are modifiable through intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Italian Journal of Public Health · doi:10.2427/5768 · Cited by 3,374
Horne, R., & Weinman, J. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00057-4 · Cited by 2,201
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531 · cited 2×
“The QA tool was adapted from Pasma et al 21 based on recommendations from Sanderson et al. 22 Studies were assessed on methods for selecting study participants and measuring study variables, appropriate statistical analyses, loss to follow-up and removal of nonpatient-initiated nonadherence (eg, due to contraindicatio…”
MethodHershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870
Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2114-5 · Cited by 708 · cited 1×
“A previous review of HT adherence and persistence concluded that little was known about the impact of clinical, demographic, or psychological factors and highlighted a need to research modifiable factors.(16) A significant amount of research has been published since 2012, warranting an upto-date review.”
BackgroundNonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676 · cited 2×
“Experiencing more hospitalizations was associated with lower odds of adherence.(9,23,34,36) Higher monthly prescription costs were associated with decreased odds of adherence in four studies,(30,32,34,52) but two studies found no significant effects.”
BackgroundAshford, S., Edmunds, J., & French, D. P. (2010) · British Journal of Health Psychology · doi:10.1348/135910709x461752 · Cited by 673
Patient adherence and persistence with oral anticancer treatment
Ruddy, K., Mayer, E., & Partridge, A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20004 · Cited by 569 · cited 1×
“The most common measurement of adherence and persistence was prescription refill, which is known to be the most objective measure.(88) However, this measurement is still flawed, as we do not know if the patient actually took their medication.”
BackgroundBarrera, M., Glasgow, R. E., McKay, H. G., Boles, S. M., & Feil, E. G. (2002) · American Journal of Community Psychology · doi:10.1023/a:1016369114780 · Cited by 333 · cited 1×
“Several studies have shown promise for the effectiveness of social support interventions.(79,80) Self-efficacy for medication taking, defined as the patient’s confidence in their ability to take the medication as prescribed, was associated with increased odds of self-reported adherence.”
BackgroundPetrie, K. J., Perry, K., Broadbent, E., & Weinman, J. (2012) · British Journal of Health Psychology · doi:10.1111/j.2044-8287.2011.02033.x · Cited by 330
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
Makubate, B., Donnan, P. T., Dewar, J. A., Thompson, A. M., & McCowan, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.116 · Cited by 298
Patient Centered Experiences in Breast Cancer: Predicting Long-Term Adherence to Tamoxifen Use
Kahn, K. L., Schneider, E. C., Malin, J. L., Adams, J. L., & Epstein, A. M. (2007) · Medical Care · doi:10.1097/01.mlr.0000257193.10760.7f · Cited by 245 · cited 2×
“Women who experienced menopause-related side effects were up to three times less likely to persist(10,49,50) in three studies but more likely to persist with treatment in two studies.(48,51) Hair thinning was associated with increased odds of persistence, but headaches and loss of appetite showed the opposite effect.”
BackgroundThe value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study
McCowan, C., Wang, S., Thompson, A. M., Makubate, B., & Petrie, D. J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.464 · Cited by 137 · cited 1×
“Studies had to be conducted in clinical practice, as adherence rates are often higher in clinical trials.(20) After removing duplicates, one author (ZM) Table 1 inclusion and exclusion criteria for studies in the review Inclusion criteria Exclusion criteria Patients were all female and aged .”
MethodCluze, C., Rey, D., Huiart, L., BenDiane, M. K., Bouhnik, A. D., Berenger, C., Carrieri, M. P., & Giorgi, R. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr330 · Cited by 133
Bender, C. M., Gentry, A. L., Brufsky, A. M., Casillo, F. E., Cohen, S. M., Dailey, M. M., Donovan, H. S., Dunbar-Jacob, J., Jankowitz, R. C., Rosenzweig, M. Q., et al. (2014) · Oncology Nursing Forum · doi:10.1188/14.onf.274-285 · Cited by 131 · cited 2×
“Hot flushes/vasomotor symptoms, incontinence, gastrointestinal symptoms and sex-related symptoms were not associated with adherence, whereas weight concerns were associated with decreased odds of adherence.(40,41) Cognitive, gynecological, musculoskeletal and sleep/fatigue-related symptoms were associated with lower o…”
BackgroundHuiart, L., Bouhnik, A.-D., Rey, D., Tarpin, C., Cluze, C., Bendiane, M. K., Viens, P., & Giorgi, R. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.004 · Cited by 97 · cited 1×
“Three studies found that women reporting low levels of social support were less likely to persist with treatment.(10,64,70) Discussion This article reviewed the evidence for clinical, demographic and psychosocial predictors of HT adherence and persistence to present a holistic view of the evidence base.”
BackgroundSheppard, V. B., Faul, L. A., Luta, G., Clapp, J. D., Yung, R. L., Wang, J. H.-Y., Kimmick, G., Isaacs, C., Tallarico, M., Barry, W. T., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.7367 · Cited by 91 · cited 1×
“Three studies found that women reporting low levels of social support were less likely to persist with treatment.(10,64,70) Discussion This article reviewed the evidence for clinical, demographic and psychosocial predictors of HT adherence and persistence to present a holistic view of the evidence base.”
BackgroundFont, R., Espinas, J. A., Gil-Gil, M., Barnadas, A., Ojeda, B., Tusquets, I., Segui, M. A., Margelí, M., Arcusa, A., Prat, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.389 · Cited by 79
Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy
Kimmick, G., Edmond, S. N., Bosworth, H. B., Peppercorn, J., Marcom, P. K., Blackwell, K., Keefe, F. J., & Shelby, R. A. (2015) · The Breast · doi:10.1016/j.breast.2015.06.010 · Cited by 72
Wouters, H., Stiggelbout, A. M., Bouvy, M. L., Maatman, G. A., Van Geffen, E. C. G., Vree, R., Nortier, J. W., & Van Dijk, L. (2014) · Clinical Breast Cancer · doi:10.1016/j.clbc.2014.04.005 · Cited by 46 · cited 1×
“Three studies found a positive relationship between perceived self-efficacy for medication taking and adherence.(27,29,69) Variables relating to patient–physician relationship tended to be associated with adherence.”
Background
Cited by
Understanding tamoxifen adherence in women with breast cancer: A qualitative study
Moon, Z., Moss‐Morris, R., Hunter, M. S., & Hughes, L. D. (2017) · British Journal of Health Psychology · doi:10.1111/bjhp.12266 · Cited by 112
Self-citationKonstantinou, P., Kassianos, A. P., Georgiou, G., Panayides, A., Papageorgiou, A., Almas, I., Wozniak, G., & Karekla, M. (2020) · Translational Behavioral Medicine · doi:10.1093/tbm/ibaa118 · Cited by 89
Toivonen, K., Williamson, T., Carlson, L., Walker, L., & Campbell, T. (2020) · Cancers · doi:10.3390/cancers13010107 · Cited by 77
Bright, E. E., Finkelstein, L. B., Nealis, M. S., Genung, S. R., Wrigley, J., Gu, H. C. J., Schmiege, S. J., & Arch, J. J. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00697 · Cited by 74
A systematic review of interventions to improve adherence to endocrine therapy
Heiney, S. P., Parker, P. D., Felder, T. M., Adams, S. A., Omofuma, O. O., & Hulett, J. M. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5012-7 · Cited by 69
Metadata
- Authors
- Moon, Z., Moss-Morris, R., Hunter, M. S., Carlisle, S., & Hughes, L. D.
- Venue
- Patient Preference and Adherence
- Publisher
- Informa UK Limited
- Published
- 2017-02
- Volume
- Volume 11
- Pages
- 305-322
- ISSN
- 1177-889X (ISSN-L)
- OpenAlex
- W2591189079
- Cited by
- 148
- References
- 21
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.